Pain relief and quality-of-life improvement after spinal cord stimulation in painful diabetic polyneuropathy: A pilot study

British Journal of Anaesthesia

Volumn 109, Issue 4, 2012, Pages 623-629

  Pluijms, W A ^a   Slangen, R ^a   Bakkers, M ^a   Faber, C G ^a   Merkies, I S J ^a,b   Kessels, A G ^a   Dirksen, C D ^a   Joosten, E A ^a   Reulen, J P H ^a   Van Dongen, R T ^c   Schaper, N C ^a   Van Kleef, M ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Infection and Immunology   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Diabetic neuropathies; Electric stimulation therapy; Pain management; Spinal cord; Treatment outcome

Indexed keywords

ADULT; AGED; ANALGESIA; ARTICLE; CLINICAL ARTICLE; DIABETIC NEUROPATHY; FEASIBILITY STUDY; FEMALE; HUMAN; IMPLANTATION; MALE; NEUROPATHIC PAIN; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PAINFUL DIABETIC POLYNEUROPATHY; PILOT STUDY; PREDICTOR VARIABLE; PRIORITY JOURNAL; QUALITY OF LIFE; RATING SCALE; SENSORY ANALYSIS; SLEEP QUALITY; SPINAL CORD STIMULATION; THERAPY EFFECT; TOTAL QUALITY MANAGEMENT; TREATMENT RESPONSE;

EID: 84866399750     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aes251     Document Type: Article

References (30)

1. Shaw JE, Zimmet PZ, Gries FA, Ziegler D. Epidemiology of diabetic neuropathy. In: Gries FA, Cameron NE, Low PA, Ziegler D, eds. Textbook of Diabetic Neuropathy. New York: Thieme, 2003; 64-82
2. Daousi C, MacFarlane IA, Woodward A, Nurmikko TJ, Bundred PE, Benbow SJ. Chronic painful peripheral neuropathy in an urban community: a controlled comparison of people with and without diabetes. Diabet Med 2004; 21: 976-82 (Pubitemid 39215316)
3. Davies M, Brophy S, Williams R, Taylor A. The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes. Diabetes Care 2006; 29: 1518-22 (Pubitemid 44127574)
4. Ziegler D, Rathmann W, Dickhaus T, Meisinger C, Mielck A. Prevalence of polyneuropathy in pre-diabetes and diabetes is associated with abdominal obesity and macroangiopathy: the MONICA/KORA Augsburg Surveys S2 and S3. Diabetes Care 2008; 31: 464-9
5. Gore M, Brandenburg NA, Hoffman DL, Tai KS, Stacey B. Burden of illness in painful diabetic peripheral neuropathy: the patients' perspectives. J Pain 2006; 7: 892-900 (Pubitemid 44854739)
6. Jensen TS, Backonja MM, Hernandez Jimenez S, Tesfaye S, Valensi P, Ziegler D. New perspectives on the management of diabetic peripheral neuropathic pain. Diab Vasc Dis Res 2006; 3: 108-19 (Pubitemid 44638385)
7. Tesfaye S, Watt J, Benbow SJ, Pang KA, Miles J, MacFarlane IA. Electrical spinal-cord stimulation for painful diabetic peripheral neuropathy. Lancet 1996; 348: 1698-701 (Pubitemid 27007534)
8. Daousi C, Benbow SJ, MacFarlane IA. Electrical spinal cord stimulation in the long-term treatment of chronic painful diabetic neuropathy. Diabet Med 2005; 22: 393-8 (Pubitemid 40516236)
9. de Vos CC, Rajan V, Steenbergen W, van der Aa HE, Buschman HP. Effect and safety of spinal cord stimulation for treatment of chronic pain caused by diabetic neuropathy. J Diabetes Complications 2009; 23: 40-5
10. Galer BS, Gianas A, Jensen MP. Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life. Diabetes Res Clin Pract 2000; 47: 123-8 (Pubitemid 30009719)
11. Dworkin RH, Turk DC, Wyrwich KW, et al. Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain 2008; 9: 105-21 (Pubitemid 351147828)
12. Jensen MP, McFarland CA. Increasing the reliability and validity of pain intensity measurement in chronic pain patients. Pain 1993; 55: 195-203 (Pubitemid 23323167)
13. Farrar JT, Young JP Jr, LaMoreaux L, Werth JL, Poole RM. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 2001; 94: 149-58 (Pubitemid 33016608)
14. Farrar JT. What is clinically meaningful: outcome measures in pain clinical trials. Clin J Pain 2000; 16: S106-12 (Pubitemid 30395253)
15. The EuroQol Group. EuroQol-a new facility for the measurement of health-related quality of life. Health Policy 1990; 16: 199-208
16. Dolan P. Modeling valuations for EuroQol health states. Med Care 1997; 35: 1095-108 (Pubitemid 127453463)
17. Aaronson NK, Muller M, Cohen PD, et al. Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. J Clin Epidemiol 1998; 51: 1055-68 (Pubitemid 28527161)
18. van der Zee K, Sanderman R, Heyink J. De psychometrische kwalteiten van de MOS 36-item Short Form Health Survey (SF-36) in een Nederlandse populatie. T Soc Gezondheidsz 1993; 71: 183-91
19. Ware JE Jr. SF-36 health survey update. Spine (Phila Pa 1976) 2000; 25: 3130-9
20. Beck A, Steer R, Brown G. Manual for the Beck Depression Inventory-II. San Antonio, TX: Psychological Corporation, 1996
21. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961; 4: 561-71
22. Feldman EL, Stevens MJ, Thomas PK, Brown MB, Canal N, Greene DA. A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care 1994; 17: 1281-9 (Pubitemid 24324972)
23. Kimura J. Electrodiagnosis in Disease of Nerve and Muscle: Principles and Practice, in Principles of Nerve Conduction Studies. Philadelphia: FA Davis, 1983
24. Martina IS, van Koningsveld R, Schmitz PI, van der Meche FG, van Doorn PA. Measuring vibration threshold with a graduated tuning fork in normal aging and in patients with polyneuropathy. European Inflammatory Neuropathy Cause and Treatment (INCAT) group. J Neurol Neurosurg Psychiatry 1998; 65: 743-7 (Pubitemid 28486656)
25. Merkies IS, Schmitz PI, van der Meche FG, van Doorn PA. Psychometric evaluation of a new sensory scale in immune-mediated polyneuropathies. Inflammatory Neuropathy Cause and Treatment (INCAT) Group. Neurology 2000; 54: 943-9 (Pubitemid 30111356)
26. van Nes SI, Faber CG, Hamers RM, et al. Revising two-point discrimination assessment in normal aging and in patients with polyneuropathies. J Neurol Neurosurg Psychiatry 2008; 79: 832-4 (Pubitemid 351914736)
27. Galer BS, Jensen MP. Development and preliminary validation of a pain measure specific to neuropathic pain: the Neuropathic Pain Scale. Neurology 1997; 48: 332-8 (Pubitemid 27087598)
28. Kravos A, Bubnic-Sotosek K. Ankle-brachial index screening for peripheral artery disease in asymptomatic patients between 50 and 70 years of age. J Int Med Res 2009; 37: 1611-9
29. Sindou MP, Mertens P, Bendavid U, Garcia-Larrea L, Mauguiere F. Predictive value of somatosensory evoked potentials for longlasting pain relief after spinal cord stimulation: practical use for patient selection. Neurosurgery 2003; 52: 1374-83; discussion 83-4
30. van Eijs F, Smits H, Geurts JW, et al. Brush-evoked allodynia predicts outcome of spinal cord stimulation in complex regional pain syndrome type 1. Eur J Pain 2009; 14: 164-9